Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study

Abstract Objective Controversy still exists regarding the volume of radiation for head and neck cancer of unknown primary (HNCUP). Theoretically, elective mucosal irradiation (EMI) should achieve a balance between survival and toxicity. This prospective study was conducted to evaluate the long‐term...

Full description

Bibliographic Details
Main Authors: Shengjin Dou, Rongrong Li, Lin Zhang, Zhuoying Wang, Li Xie, Chenping Zhang, Guopei Zhu
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.2856
_version_ 1811153640059043840
author Shengjin Dou
Rongrong Li
Lin Zhang
Zhuoying Wang
Li Xie
Chenping Zhang
Guopei Zhu
author_facet Shengjin Dou
Rongrong Li
Lin Zhang
Zhuoying Wang
Li Xie
Chenping Zhang
Guopei Zhu
author_sort Shengjin Dou
collection DOAJ
description Abstract Objective Controversy still exists regarding the volume of radiation for head and neck cancer of unknown primary (HNCUP). Theoretically, elective mucosal irradiation (EMI) should achieve a balance between survival and toxicity. This prospective study was conducted to evaluate the long‐term benefit of EMI in Chinese HNCUP patients. Methods A phase II, single‐arm trial was performed at two centers in China. HNCUP patients with pathologically confirmed metastatic squamous cell carcinoma or poorly differentiated carcinoma were enrolled. Patients with metastatic lymph nodes limited to level IV and/or the supraclavicular fossa were excluded. The EMI approach was specifically customized to Chinese patients by differentiating HNCUP as putative nasopharyngeal carcinoma (NPC) or non‐putative NPC. The primary endpoint was 3‐year mucosal recurrence‐free survival (MRFS). Results A total of 48 patients were enrolled between 02/02/2010 and 08/01/2018; 46 patients were analyzed, including 24 putative NPC and 22 non‐putative NPC patients. No primary recurrence was observed during a median follow‐up period of 70 months, and only 1 patient experienced out of field recurrence in the contralateral neck. The 3‐year MRFS was 90.6% (95%CI: 76.4%‐96.4%). The 5‐year MRFS, regional‐recurrence free survival (RRFS) and overall survival (OS) were 90.6% (95%CI: 76.4%‐96.4%), 86.0% (95%CI: 71.1%‐93.7%), and 90.6% (95%CI: 76.4%‐96.4%), respectively. No grade 4 acute or late toxicities occurred, and the most frequent grade 3 acute toxicity was oral mucositis (45.7%). Conclusion To the best of our knowledge, this is the first prospective study to evaluate the long‐term outcomes of EMI in Chinese HNCUP patients. Excellent MRFS and OS rates were observed. Further randomized studies are warranted.
first_indexed 2024-03-08T04:03:13Z
format Article
id doaj.art-071217e7aec44764b65c53b177e7ea72
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-03-08T04:03:13Z
publishDate 2020-03-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-071217e7aec44764b65c53b177e7ea722024-02-09T09:26:02ZengWileyCancer Medicine2045-76342020-03-01951712172010.1002/cam4.2856Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP studyShengjin Dou0Rongrong Li1Lin Zhang2Zhuoying Wang3Li Xie4Chenping Zhang5Guopei Zhu6Radiotherapy Division Department of Oral and Maxillofacial‐Head Neck Oncology Shanghai Ninth People’s Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai ChinaRadiotherapy Division Department of Oral and Maxillofacial‐Head Neck Oncology Shanghai Ninth People’s Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai ChinaRadiotherapy Division Department of Oral and Maxillofacial‐Head Neck Oncology Shanghai Ninth People’s Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Head and Neck Surgery Fudan University Shanghai Cancer Center Shanghai ChinaClinical Research Center Shanghai Jiao Tong University School of Medicine Shanghai ChinaNational Clinical Research Center for Oral Diseases Shanghai ChinaRadiotherapy Division Department of Oral and Maxillofacial‐Head Neck Oncology Shanghai Ninth People’s Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai ChinaAbstract Objective Controversy still exists regarding the volume of radiation for head and neck cancer of unknown primary (HNCUP). Theoretically, elective mucosal irradiation (EMI) should achieve a balance between survival and toxicity. This prospective study was conducted to evaluate the long‐term benefit of EMI in Chinese HNCUP patients. Methods A phase II, single‐arm trial was performed at two centers in China. HNCUP patients with pathologically confirmed metastatic squamous cell carcinoma or poorly differentiated carcinoma were enrolled. Patients with metastatic lymph nodes limited to level IV and/or the supraclavicular fossa were excluded. The EMI approach was specifically customized to Chinese patients by differentiating HNCUP as putative nasopharyngeal carcinoma (NPC) or non‐putative NPC. The primary endpoint was 3‐year mucosal recurrence‐free survival (MRFS). Results A total of 48 patients were enrolled between 02/02/2010 and 08/01/2018; 46 patients were analyzed, including 24 putative NPC and 22 non‐putative NPC patients. No primary recurrence was observed during a median follow‐up period of 70 months, and only 1 patient experienced out of field recurrence in the contralateral neck. The 3‐year MRFS was 90.6% (95%CI: 76.4%‐96.4%). The 5‐year MRFS, regional‐recurrence free survival (RRFS) and overall survival (OS) were 90.6% (95%CI: 76.4%‐96.4%), 86.0% (95%CI: 71.1%‐93.7%), and 90.6% (95%CI: 76.4%‐96.4%), respectively. No grade 4 acute or late toxicities occurred, and the most frequent grade 3 acute toxicity was oral mucositis (45.7%). Conclusion To the best of our knowledge, this is the first prospective study to evaluate the long‐term outcomes of EMI in Chinese HNCUP patients. Excellent MRFS and OS rates were observed. Further randomized studies are warranted.https://doi.org/10.1002/cam4.2856head and neckintensity‐modulated radiation therapylymph node metastasismucosal irradiationradiotherapyunknown primary
spellingShingle Shengjin Dou
Rongrong Li
Lin Zhang
Zhuoying Wang
Li Xie
Chenping Zhang
Guopei Zhu
Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study
Cancer Medicine
head and neck
intensity‐modulated radiation therapy
lymph node metastasis
mucosal irradiation
radiotherapy
unknown primary
title Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study
title_full Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study
title_fullStr Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study
title_full_unstemmed Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study
title_short Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study
title_sort long term results of elective mucosal irradiation for head and neck cancer of unknown primary in chinese population the emicup study
topic head and neck
intensity‐modulated radiation therapy
lymph node metastasis
mucosal irradiation
radiotherapy
unknown primary
url https://doi.org/10.1002/cam4.2856
work_keys_str_mv AT shengjindou longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy
AT rongrongli longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy
AT linzhang longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy
AT zhuoyingwang longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy
AT lixie longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy
AT chenpingzhang longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy
AT guopeizhu longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy